Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

UNICEF in negotiations to buy COVID-19 drug for 4.5 million patients in poor countries

Ruth Okwumbu-ImafidonbyRuth Okwumbu-Imafidon
3 years ago
in Coronavirus
UNICEF in negotiations to buy COVID-19 drug for 4.5 million patients in poor countries
Share on FacebookShare on TwitterShare on Linkedin

The United Nations Children’s Fund (UNICEF) is currently in negotiations to purchase the steroid-dexamethasone  – for 4.5 million coronavirus infected patients in low and middle-income countries.

According to a report from Reuters, the advance purchase will be made under a deal negotiation led by UNITAID and Wellcome.

According to a joint statement from both agencies, the deal is part of the World Health Organization (WHO)’s plan to accelerate access to therapeutics in the battle against the global pandemic.

“With this advanced purchase we aim to ensure equitable access for low- and middle-income countries for the treatment of COVID-19 with the life-saving drug dexamethasone, and avoid shortages resulting from high levels of demand from other parts of the world,” said Philippe Duneton, acting executive director of UNITAID said in the statement.

The initial purchase will be made for up to 4.5 million people in low and middle-income countries, the agencies said on Friday.

READ MORE: African Development Bank to launch African Economic Outlook 2020 Supplement

The steroid dexamethasone, originally a corticosteroid medication used in the treatment of conditions such as asthma, inflammatory disorders and certain cancers, was discovered to be effective in treating severe or critical COVID-19 patients on ventilators, following clinical trials in the United Kingdom.

Earlier in June, Nigeria’s Minister of Health, Dr. Osagie Ehanire had called on frontline clinicians to consider the use of dexamethasone in the treatment of COVID-19 across the country.

Speaking during one of the daily briefings by the Task Force on COVID-19, Ehanire noted that the drug had been in use since the 1960s and its side effects are well known to medical practitioners

READ ALSO: World Bank 2020 stats: Developing nations’ debt hit $7.8 trillion

“Luckily, this medicine is not new. It is a well-known steroid that is used for other purposes but was found to be useful in this case (treatment of COVID-19). So it is easy to try it out because we already know its side effects. It is not a product that will get you worried about its possible side effects.

“So we are going to ask our clinician to also consider adding it to their trials and see what result it brings in our circumstances,” he said in the briefing, acknowledging the results from the UK clinical trials.

The World Health Organisation also welcomed the results of the initial clinical trial results from the United Kingdom showing that dexamethasone could be lifesaving for patients who are critically ill with COVID-19 and for patients on ventilators.

 

Related

Tags: COVID-19 PandemicDexamethasoneDr Osagie EhanireUNITAIDUnited Nations Children’s Fund (UNICEF)WHO

Leave a Reply Cancel reply

HFM
Mega Millions
Mega Millions
Standard
Patricia





NM newsletters

Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

Recent News

  • Vice President Osinbajo says cashless policy will help track election financing
  • Lagos moves to eliminate quacks in real estate sector
  • Nigeria’s bonds jettisoned at fastest pace in 3 months following Moody’s downgrade

Follow us on social media:

Recent News

Vice President Osinbajo says cashless policy will help track election financing 

Vice President Osinbajo says cashless policy will help track election financing

January 30, 2023
Lagos moves to eliminate quacks in real estate sector

Lagos moves to eliminate quacks in real estate sector

January 30, 2023
  • Home
  • Exclusives
  • Markets
  • Industries
  • Economy
  • Business News
  • Financial Literacy
  • Lifestyle
  • Opinions

© 2023 Nairametrics

No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds

© 2023 Nairametrics